Loading company…
Thousand Oaks Biopharmaceuticals, Inc. is a Nantong-based biopharmaceutical technology service provider focused on CRO and CMO work.
Established in 2017 and based in Nantong, China, the company offers CDMO services for biopharmaceutical products, including a transient transfection platform that provides proteins for drug screening, along with stock solutions and preparation filling. Founder and chairman Dr. Shun luo previously worked at Serono, JRH Biosciences and Amgen. In 2019 it set up a US entity, and in 2020 it produced COVID-19 vaccines. It is listed at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in